|PDGM is another biotech in lock-up expiration hell. Shares unlocked in January '01, and the 144s have been pouring out. It seems to be mostly VC at this point.|
This link should work indefinitely for keeping track of the insider transactions:
From their website:
>>Paradigm Genetics is industrializing the process of gene function determination for four major sectors of the global economy: human health, nutrition, crop production, and industrial products.<<
It is my understanding that charecterization of gene function is a major bottleneck in drug discovery. Their Gene Function Factory technology is manifest in workstations, so PDGM could arguably be a tool company.